Acyclovir suppressive therapy dosage

Suppressive therapy with acyclovir, famciclovir, or valacyclovir to a high-dose suppressive valacyclovir group (1,000 mg bid) in. ART

Neonatal Herpes Encephalitis Newborn Infections Following the initial acyclovir therapy, infants may need additional oral acyclovir suppressive therapy for

cy of acyclovir-resistance of the virus population isolated directly from lesions of genital herpes. This finding suggests that long-term, low-dose acyclovir suppressive therapy for Antiviral Chemistry Chemotherapy 3 239 Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of

acyclovir-suppressive therapy. Thus, the low dose of acyclovir suppressive therapy did not affect the susceptibility to acyclovir or increase the fre-quency of acyclovir-resistant viruses in the geni-tal lesions. Keywords: genital herpes, herpes simplex virus, acyclovir, susceptibility Introduction 2024 International Medical Press

Adolescents with frequent recurrences of genital herpes may benefit fromcontinual suppressive antiviral therapy; the dosage of oral acyclovir

Acyclovir, valacyclovir, and famciclovir are effective for suppressive and episodic therapy. Valacyclovir is the prodrug of acyclovir, and has

first recurrence of symptoms in favor of suppressive dosing (P 0.0001). Suppressive therapy with oral acyclovir, famciclovir or valacyclovir

cy of acyclovir-resistance of the virus population isolated directly from lesions of genital herpes. This finding suggests that long-term, low-dose acyclovir suppressive therapy for Antiviral Chemistry Chemotherapy 3 239 Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of

acyclovir-suppressive therapy. Thus, the low dose of acyclovir suppressive therapy did not affect the susceptibility to acyclovir or increase the fre-quency of acyclovir-resistant viruses in the geni-tal lesions. Keywords: genital herpes, herpes simplex virus, acyclovir, susceptibility Introduction 2024 International Medical Press